Current Approaches to Neuromodulation in Primary Headaches: Focus on Vagal Nerve and Sphenopalatine Ganglion Stimulation.

Journal Information

Full Title: Curr Pain Headache Rep

Abbreviation: Curr Pain Headache Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychophysiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest Francesca Puledda declares no conflict of interest. Peter J. Goadsby declares grant support and personal fees from Allergan, eNeura Inc. and Amgen Inc.; he also declares personal fees from Autonomic Technologies Inc., Alder Biopharmaceuticals, Pfizer Inc., Dr. Reddy’s Laboratories, Zosano Pharma Corporation, Colucid Pharmaceuticals, Ltd., Eli-Lilly and Company, Avanir Pharmaceuticals, WL Gore & Associates, Heptares Therapeutics, Nupathe Inc., Teva, Cipla Ltd., Ajinomoto Pharmaceuticals Co., Akita Biomedical, Wells Fargo, Ethicon, USA, EMKinetics, Promius Pharma, Supernus and medicoegal work; and personal fees from Journal Watch and Up-to-Date for editorial work. He also declares personal fees and stock options (no commercial product) from Trigemina Inc. He also declares a patent pending for magnetic stimulation for headache."

Evidence found in paper:

"Compliance with Ethical Standards: Conflict of InterestFrancesca Puledda declares no conflict of interest. Peter J. Goadsby declares grant support and personal fees from Allergan, eNeura Inc. and Amgen Inc.; he also declares personal fees from Autonomic Technologies Inc., Alder Biopharmaceuticals, Pfizer Inc., Dr. Reddy’s Laboratories, Zosano Pharma Corporation, Colucid Pharmaceuticals, Ltd., Eli-Lilly and Company, Avanir Pharmaceuticals, WL Gore & Associates, Heptares Therapeutics, Nupathe Inc., Teva, Cipla Ltd., Ajinomoto Pharmaceuticals Co., Akita Biomedical, Wells Fargo, Ethicon, USA, EMKinetics, Promius Pharma, Supernus and medicoegal work; and personal fees from Journal Watch and Up-to-Date for editorial work. He also declares personal fees and stock options (no commercial product) from Trigemina Inc. He also declares a patent pending for magnetic stimulation for headache.: Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025